PAHC vs TECH: fair value comparison
Phibro Animal Health Corporation and Bio-Techne Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, PAHC currently sits closer to the top of our discount ranking. TECH carries the stronger quality grade.
| PAHC | TECH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $38.26 | $72.12 |
| 12-month range | $29.67–$54.52 | $50.79–$72.18 |
| Sector rank | #49 of 113 Healthcare | #52 of 113 Healthcare |
| Quality grade | C | A |
| Momentum grade | C | — |
| Leverage | High | Low |
| Margin trend | Expanding | Stable |
| Revenue growth | Strong | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: PAHC fair value analysis · TECH fair value analysis